Violich Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,525
| Closed | -$205K | – | 112 |
|
|
2023
Q4 | $205K | Buy |
+2,525
| New | +$196K | 0.03% | 98 |
|
|
2023
Q2 | – | Sell |
-2,575
| Closed | -$214K | – | 110 |
|
|
2023
Q1 | $214K | Hold |
2,575
| – | – | 0.04% | 101 |
|
|
2022
Q4 | $221K | Buy |
+2,575
| New | +$204K | 0.04% | 100 |
|
|
2021
Q4 | – | Sell |
-12,960
| Closed | -$905K | – | 120 |
|
|
2021
Q3 | $905K | Sell |
12,960
-13,900
| -52% | -$977K | 0.15% | 67 |
|
|
2021
Q2 | $1.85M | Sell |
26,860
-500
| -2% | -$33.4K | 0.31% | 44 |
|
|
2021
Q1 | $1.77M | Sell |
27,360
-500
| -2% | -$32.2K | 0.32% | 45 |
|
|
2020
Q4 | $1.62M | Sell |
27,860
-350
| -1% | -$21.1K | 0.31% | 41 |
|
|
2020
Q3 | $1.78M | Sell |
28,210
-1,800
| -6% | -$125K | 0.38% | 41 |
|
|
2020
Q2 | $2.31M | Sell |
30,010
-200
| -0.7% | -$15.3K | 0.51% | 37 |
|
|
2020
Q1 | $2.26M | Sell |
30,210
-1,550
| -5% | -$107K | 0.6% | 35 |
|
|
2019
Q4 | $2.06M | Sell |
31,760
-3,500
| -10% | -$228K | 0.45% | 40 |
|
|
2019
Q3 | $2.23M | Sell |
35,260
-1,750
| -5% | -$114K | 0.54% | 37 |
|
|
2019
Q2 | $2.5M | Sell |
37,010
-7,605
| -17% | -$500K | 0.61% | 35 |
|
|
2019
Q1 | $2.9M | Sell |
44,615
-3,075
| -6% | -$204K | 0.74% | 34 |
|
|
2018
Q4 | $2.98M | Sell |
47,690
-35,870
| -43% | -$2.51M | 0.85% | 32 |
|
|
2018
Q3 | $6.45M | Sell |
83,560
-841
| -1% | -$63.5K | 1.47% | 23 |
|
|
2018
Q2 | $5.98M | Buy |
84,401
+575
| +0.7% | +$40.6K | 1.5% | 23 |
|
|
2018
Q1 | $6.32M | Sell |
83,826
-500
| -0.6% | -$39.7K | 1.69% | 22 |
|
|
2017
Q4 | $6.04M | Sell |
84,326
-2,605
| -3% | -$198K | 1.54% | 22 |
|
|
2017
Q3 | $7.04M | Buy |
86,931
+1,649
| +2% | +$126K | 1.92% | 17 |
|
|
2017
Q2 | $6.04M | Buy |
85,282
+800
| +0.9% | +$53.2K | 1.76% | 21 |
|
|
2017
Q1 | $5.74M | Sell |
84,482
-200
| -0.2% | -$14.1K | 1.73% | 18 |
|
|
2016
Q4 | $5.55M | Buy |
84,682
+8,702
| +11% | +$647K | 1.71% | 20 |
|
|
2016
Q3 | $6.01M | Buy |
75,980
+900
| +1% | +$73.1K | 2.11% | 15 |
|
|
2016
Q2 | $6.26M | Buy |
75,080
+4,105
| +6% | +$364K | 1.98% | 16 |
|
|
2016
Q1 | $6.52M | Buy |
70,975
+20,655
| +41% | +$1.86M | 2.1% | 13 |
|
|
2015
Q4 | $5.09M | Buy |
50,320
+5,425
| +12% | +$564K | 1.69% | 18 |
|
|
2015
Q3 | $4.41M | Buy |
44,895
+1,500
| +3% | +$167K | 1.54% | 18 |
|
|
2015
Q2 | $5.08M | Buy |
43,395
+925
| +2% | +$101K | 1.66% | 16 |
|
|
2015
Q1 | $4.17M | Buy |
42,470
+3,735
| +10% | +$379K | 1.35% | 23 |
|
|
2014
Q4 | $3.65M | Buy |
38,735
+12,950
| +50% | +$1.34M | 1.16% | 26 |
|
|
2014
Q3 | $2.75M | Buy |
25,785
+19,980
| +344% | +$1.96M | 0.89% | 29 |
|
|
2014
Q2 | $481K | Buy |
+5,805
| New | +$452K | 0.16% | 72 |
|
Other funds holding GILD
Violich Capital Management's GILD Position: Q1 2024 in Review
Violich Capital Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 2,525 shares — an estimated $205K sold.
Violich Capital Management first reported a position in GILD in Q2 2014 and held it in 33 quarters. The position peaked at $7.04M in Q3 2017. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.
- Violich Capital Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
- Violich Capital Management sold 2,525 Gilead Sciences shares in Q1 2024, an estimated $205K.
- Violich Capital Management first reported a position in Gilead Sciences in Q2 2014 and held it in 33 quarters.
- Violich Capital Management's Gilead Sciences position peaked at $7.04M in Q3 2017.
- 1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.
Based on Violich Capital Management's 13F filing for Q1 2024, filed 30 Apr 2024.